EpiPen's price has ballooned about 400% since 2008, rising from about a $100 list price to $500 today. The EpiPen is one of the most important life-saving medical innovations for people with severe food allergies—which affect as many as 15 million Americans and 1 in 13 children in the United States. But its price has exploded over the last decade despite few upgrades to the product itself. The product's lack of competitors is likely a significant driver of the costs. [...] [The] EpiPen enjoys a near-monopoly on the market with annual sales of more than $1.3 billion and nearly 90% U.S. market share.
(Score: 2, Insightful) by Anonymous Coward on Tuesday August 23 2016, @10:53PM
state-owned, public-funded medical research
This, together with GP's on-target use of "Communist", gets top marks from me.
...and isn't most fundamental biological research already being done in public universities?
Biologists and physicians, am I wrong?
...and for those who aren't aware, USA's healthcare costs are the highest[1] on the planet and the results are far from the best.
[1] USAians spend ~3x what Britons do and Cuba (with its minimal monetary resources) bests USA in several ways in quality of outcome--largely through easy access and early intervention.
-- OriginalOwner_ [soylentnews.org]